STARTED EVALUATING AN APPLICATION TO EXTEND THE USE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, TO ADOLESCENTS AGED 12 TO 17
https://www.marketscreener.com/quote/stock/NOVAVAX-INC-58256108/news/EMA-Says-Looking-At-Extension-Of-Novavax-COVID-Shot-For-Adolescents-39913191/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.